Cleerly We Do More.
21st Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT)
July 9-12, San Diego, CA
BOOTH 301
Experience Cleerly at SCCT 2026
Cleerly invites you to the SCCT’s premier global meeting dedicated to cardiovascular CT, bringing together physicians, trainees, technologists and healthcare professionals for a comprehensive look at the field’s latest advances.
Stop by Booth 301 for live demos of Cleerly's technology, clinical evidence, and expert discussions with our leadership team throughout the conference. We’ll showcase Cleerly’s personalized coronary CT analysis, designed to streamline workflows, enhance diagnostic accuracy and empower healthcare professionals to make confident, data-driven decisions for better patient outcomes.
Don’t miss your chance to experience the future of cardiac care firsthand.
SCCT 2026
Visit us at: BOOTH 301
Book a private meeting with Cleerly
Meet Cleerly Leadership
Join us for an exclusive meet and greet with Cleerly Executives! Snacks and coffee will be provided.
Booth 301
July 11, 1:40 - 2:40 PM PT
James K. Min, MD
Founder and CEO
Parker Cassidy
Chief Operating Officer
Jim Hartman
Chief Commercial Officer
Udo Hoffmann, MD
Chief Medical, Scientific and AI Officer
Kimberly McCombs
Chief Strategy Officer
Christine Pellizzari
Chief Legal Officer
Michal Sofka, PhD
Chief Technology Officer
Join Cleerly at SCCT 2026 Events
Demonstrations daily // Friday and Saturday at Booth 301
Thursday, July 9
1:00 PM
AI and Innovations Symposium
Location: Chula Vista 1
Friday, July 10
7:00 AM – 7:50 AM
Cleerly Breakfast Symposia: The Importance of Serial Scanning – Monitoring Plaque Progression
James K. Min, MD – CEO, Cleerly
Michael Coords, MD - Medical Director Cardiovascular Imaging, RadNet West
Neerav Sheth, MD, MBA - Interventional Cardiologist, Cardiology Consultants of Philadelphia
Brittany Weber, MD, PhD - Director, Cardio-Rheumatology/Cardio-Dermatology Program, UT Southwestern
9:00 AM – 7:15 PM
Exhibit Hall Hours
9:30 – 10:15 PM
Beyond Risk Factors: Additive Role of Noncalcified Plaque Volume in Risk Stratification for Cardiovascular Events | Poster Session 2, #417
Age- and Sex- Specific Plaque Percentiles and Absolute Risk Zones from AI-QCT: Insights from CONFIRM2 | Poster Session 13, #526
3:30 – 5:00 PM
AI Plaque Wars! | Chula Vista - 6
5:34 – 5:42 PM
Novel Technologies: Cleerly Industry Presentation | Chula Vista - 4
Saturday, July 11
9:00 AM – 4:05 PM
Exhibit Hall Hours
10:55 – 11:40 AM
Poster Session 20
599. Impact of Statin and Aspirin on Plaque Composition: Data from the CONFIRM2 Registry
601. Association of Cardiac Symptoms with Quantitative Coronary Atherosclerosis, Stenosis, and Ischemia: Results from the CONFIRM2 Registry
612. AI-Derived Plaque Quantification and Risk Stratification in Asymptomatic Individual: A Sub-analysis of the CONFIRM2 Registry
628.Discordance between PREVENT Clinical Risk Score, Coronary Artery Calcium, and Quantitative Non-Calcified Plaque in Asymptomatic South Asian Adults: Insights from the SACTA Registry
1:40 - 2:40 PM
Meet and Greet Cleerly leadership in Booth #301
SCCT 2026
Visit us at: BOOTH 301
Book a private meeting with Cleerly
Cleerly’s products and services may be covered by or for use under one or more patents. See here for additional information.
